Foto dell'editore

The Moral Corporation: Merck Experiences

Louis Galambos; P. Roy Vagelos

Editore: Cambridge University Press, 2006
ISBN 10: 0521683831 / ISBN 13: 9780521683838
Usato / Soft cover / Quantità: 1
Da Book Deals (Lewiston, NY, U.S.A.)
Copie del libro da altre librerie
Mostra tutte le  copie di questo libro
Aggiungere al carrello
Prezzo: EUR 32,22
Convertire valuta
Spedizione: EUR 0,00
In U.S.A.
Destinazione, tempi e costi

Lista dei preferiti


Dati bibliografici

Titolo: The Moral Corporation: Merck Experiences

Casa editrice: Cambridge University Press

Data di pubblicazione: 2006

Legatura: Soft cover

Condizione libro: Used


This Book is in Good Condition. Clean Copy With Light Amount of Wear. 100% Guaranteed. Summary: 1. The puzzle; 2. Professional path; 3. Turn around; 4. New drugs and public safety; 5. Corporate grooming; 6. Winning in global competition; 7. Prices and public interest; 8. Moral leadership; 9. Afterwards. Codice inventario libreria ABE_book_usedgood_0521683831

Su questo libro:

Book ratings provided by GoodReads):
3,25 valutazione media
(4 valutazioni)

Riassunto: Merck and the pharmaceutical industry are headline news today. Controversies over public safety, prices, and the ability of the industry to develop the new drugs and vaccines that society needs have been covered worldwide. Roy Vagelos, who was head of research and then CEO at Merck from the mid-1970s through the early 1990s, addresses these issues here. Success with targeted research started Merck on a path that would lead to a series of block-buster therapies that carried the firm to the top of the global industry in the 1990s and Vagelos into the top position at the company. Trained as a physician and scientist, he had to learn how to run a successful business while holding to the highest principles of ethical behavior. He was not always successful. He and his co-author explain where and why he failed to achieve his goals and carefully analyze where he succeeded.

Descrizione del libro: Merck and the pharmaceutical industry are headline news. Roy Vagelos, former CEO of Merck, highlights his efforts to turn around the Merck laboratories and introduce an entirely novel approach to drug development. He and his co-author explain where and why he failed and carefully analyze where he succeeded.

Le informazioni nella sezione "Su questo libro" possono far riferimento a edizioni diverse di questo titolo.

Info su libreria e pagamento

Metodi di pagamento

La libreria accetta i seguenti metodi di pagamento:

  • American Express
  • Carte Bleue
  • Mastercard
  • Visa

[Cercare nel catalogo della libreria]

[Tutti i libri della libreria]

[Fare una domanda alla libreria]

Libreria: Book Deals
Indirizzo: Lewiston, NY, U.S.A.

Libreria AbeBooks dal: 7 maggio 2014
Valutazione libreria: 4 stelle

Condizioni di vendita:

We guarantee the condition of every book as it's described on the AbeBooks web
sites. If you're dissatisfied with your purchase (Incorrect Book/Not as
Described/Damaged) or if the order hasn't arrived, you're eligible for a refund
within 30 days of the estimated delivery date. If you've changed your mind
about a book that you've ordered, please use the Ask bookseller a question link
to contact us and we'll respond within 2 business days.

Condizioni di spedizione:

Shipping costs are based on books weighing 2.2 LB, or 1 KG. If your book order is heavy or oversized, we may contact you to let you know extra shipping is required.